Minneslate Logo

HF2047 (Legislative Session 94 (2025-2026))

Enrollee required to receive any rebates and discounts accrued directly or indirectly to health carriers.

Related bill: SF2176

AI Generated Summary

Purpose of the Bill

The purpose of this bill is to regulate how rebates and discounts from pharmaceutical manufacturers are applied to prescription drug pricing, ensuring that these benefits are passed on to the enrollees at the point of sale in Minnesota. This aims to lower out-of-pocket costs for consumers when purchasing prescription drugs.

Main Provisions

  • Cost-Sharing Reductions: The bill mandates that any rebates or discounts on prescription drugs must be directly credited to the enrollee's cost-sharing obligations (like deductibles or coinsurance) at the point of sale. This means that when someone buys a prescription drug, the price will be reduced by the total amount of rebates received for that drug.

  • Definition of Terms: It provides definitions for terms such as "defined cost-sharing," "health carrier," "price protection rebate," and "rebate," to clarify how these terms are applied within the legislation.

  • Confidentiality of Rebate Information: The bill includes strict confidentiality requirements regarding rebate information. This information is considered a trade secret and must not be publicly disclosed in a way that reveals specific details about products or manufacturers.

Significant Changes to Existing Law

  • Transparency and Savings: The bill requires transparency in how rebates and discounts affect the cost of prescription drugs for consumers, ensuring they are used to reduce the cost for the buyer at the point of sale.

  • Regulations on Rebate Disclosure: It establishes new confidentiality rules surrounding the disclosure of rebate information, highlighting its sensitive nature and protecting it as a trade secret.

  • Enforcement and Penalties: The bill enforces compliance by allowing penalties such as civil fines or license suspension for health carriers or pharmacy benefit managers that fail to adhere to these new rules.

Relevant Terms

  • Cost-Sharing
  • Rebates and Discounts
  • Prescription Drugs
  • Health Carrier
  • Pharmacy Benefit Manager
  • Confidentiality
  • Price Protection Rebate
  • Trade Secret

Bill text versions

Actions

DateChamberWhereTypeNameCommittee Name
March 09, 2025HouseFloorActionIntroduction and first reading, referred toCommerce Finance and Policy

Citations

 
[
  {
    "analysis": {
      "added": [],
      "removed": [],
      "summary": "This bill references the definition of 'health carrier' as given in section 62A.011, subdivision 2.",
      "modified": [
        "Clarifies the inclusion of pharmacy benefit managers as health carriers."
      ]
    },
    "citation": "62A.011, subdivision 2"
  },
  {
    "analysis": {
      "added": [],
      "removed": [],
      "summary": "This bill references the definition of 'pharmacy benefit manager' as given in section 62W.02, subdivision 15.",
      "modified": [
        "Ensures alignment with existing definitions when referring to pharmacy benefit management services."
      ]
    },
    "citation": "62W.02, subdivision 15"
  },
  {
    "analysis": {
      "added": [],
      "removed": [],
      "summary": "This bill ensures that rebate information remains confidential and protected under chapter 13, the Minnesota Government Data Practices Act.",
      "modified": [
        "Emphasizes the trade secret status of rebate information to protect it from public disclosure."
      ]
    },
    "citation": "chapter 13"
  }
]

Sponsors